Anti-MRSA Cephems: An Update

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 14, 2 Issues, 2016

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Anti-MRSA Cephems: An Update

Anti-Infective Agents, 1(3): 269-279.

Author(s): Dane M Springer.

Affiliation: Rib-X Pharmaceuticals, 300 George Street, New Haven, CT 06511, USA.


A review of recent developments in the field of anti-MRSA cephems is presented. The R.W. Johnson / Microcide collaboration seems to be the most advanced effort to date, but many other companies are continuing their efforts to develop a cephalosporin for use against serious Gram-positive infections such as MRSA. A detailed account of the progression of the MRSA cephem program at Bristol-Myers Squibb is provided. This work produced a number of compounds that had excellent biological activity, and were safe in a murine model of acute toxicity.


anti-mrsa cephem, mrsa cephem.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 1
Issue Number: 3
First Page: 269
Last Page: 279
Page Count: 11
DOI: 10.2174/1568012023354929
Price: $58
Superbugs USA

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science